Literature DB >> 29368284

Endoscopic gastrojejunostomy revision is more effective than medical management alone to address weight regain after RYGB.

H Mason Hedberg1,2, Alexander Trenk3, Kristine Kuchta4, John G Linn3, JoAnn Carbray3, Michael B Ujiki3.   

Abstract

BACKGROUND: Weight regain after bariatric roux-en-y gastric bypass affects up to 30% of individuals. Revisional surgery is risky, and is typically avoided in favor of dietary and psychological management. Endoscopic gastrojejunostomy revision is a low-morbidity, outpatient procedure that may be more effective than medical management alone for regain after gastric bypass.
METHODS: Two patient cohorts were retrospectively assembled. Both groups had gastric bypass, regained weight, and were cleared for revision by their surgeon, dietician, and psychologist. The revision group underwent the procedure, and the no-revision group did not, typically due to insurance issues. Weights from pre-bypass to 2 years post-revision, obesity-related comorbidities, and intraoperative factors were collected and analyzed.
RESULTS: There were 41 patients included in the revision group and 14 in the no-revision group. Up to the time of revision procedure, body mass index, and % excess weight loss between groups were similar. After revision, the groups diverged over a 2-year period, with improvement seen in the revision group and worsening in the no-revision group. The revision group showed overall improvement in comorbidities compared to the no-revision group. Analysis of intraoperative factors suggests that gastric pouch restriction in addition to stoma diameter reduction may promote weight loss.
CONCLUSIONS: In this retrospective study, endoscopic revision provided significantly greater weight loss compared to medical management alone. Results show that revision can help resolve obesity-related comorbidities. Analysis of intraoperative factors suggests that pouch reduction at time of stoma revision may improve weight loss.

Entities:  

Keywords:  Bariatric; Comorbidity; Endoscopic; Gastric bypass; Obesity

Mesh:

Year:  2018        PMID: 29368284     DOI: 10.1007/s00464-018-6073-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  26 in total

1.  Evaluation of an endoscopic suturing device for transoral outlet reduction in patients with weight regain following Roux-en-Y gastric bypass.

Authors:  P Jirapinyo; J Slattery; M B Ryan; B K Abu Dayyeh; D B Lautz; C C Thompson
Journal:  Endoscopy       Date:  2013-06-25       Impact factor: 10.093

2.  Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years.

Authors:  Nicolas V Christou; Didier Look; Lloyd D Maclean
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

3.  Weight regain following RYGB can be effectively treated using a combination of endoscopic suturing and sclerotherapy.

Authors:  Pietro Riva; Silvana Perretta; Lee Swanstrom
Journal:  Surg Endosc       Date:  2016-08-23       Impact factor: 4.584

Review 4.  Gastric bypass revision: lessons learned from 920 cases.

Authors:  R W Schwartz; W E Strodel; W S Simpson; W O Griffen
Journal:  Surgery       Date:  1988-10       Impact factor: 3.982

5.  Gastrojejunal anastomotic reduction for weight regain in roux-en-y gastric bypass patients: physiological, behavioral, and anatomical effects of endoscopic suturing and sclerotherapy.

Authors:  Pichamol Jirapinyo; Barham K Abu Dayyeh; Christopher C Thompson
Journal:  Surg Obes Relat Dis       Date:  2016-10-04       Impact factor: 4.734

6.  Endoscopic suturing for transoral outlet reduction increases weight loss after Roux-en-Y gastric bypass surgery.

Authors:  Christopher C Thompson; Bipan Chand; Yang K Chen; Daniel C DeMarco; Larry Miller; Michael Schweitzer; Richard I Rothstein; David B Lautz; James Slattery; Michele B Ryan; Stacy Brethauer; Phillip Schauer; Mack C Mitchell; Anthony Starpoli; Gregory B Haber; Marc F Catalano; Steven Edmundowicz; Annette M Fagnant; Lee M Kaplan; Mitchell S Roslin
Journal:  Gastroenterology       Date:  2013-04-05       Impact factor: 22.682

7.  Should bariatric revisional surgery be avoided secondary to increased morbidity and mortality?

Authors:  Peter T Hallowell; Thomas A Stellato; David A Yao; Ann Robinson; Margaret M Schuster; Kristen N Graf
Journal:  Am J Surg       Date:  2009-03       Impact factor: 2.565

8.  Endoluminal Revision (OverStitch (TM) , Apollo Endosurgery) of the Dilated Gastroenterostomy in Patients with Late Dumping Syndrome After Proximal Roux-en-Y Gastric Bypass.

Authors:  Christine Stier; Sonja Chiappetta
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

9.  Behavioral predictors of weight regain after bariatric surgery.

Authors:  Jacqueline Odom; Kerstyn C Zalesin; Tamika L Washington; Wendy W Miller; Basil Hakmeh; Danielle L Zaremba; Mohamed Altattan; Mamtha Balasubramaniam; Deborah S Gibbs; Kevin R Krause; David L Chengelis; Barry A Franklin; Peter A McCullough
Journal:  Obes Surg       Date:  2009-06-25       Impact factor: 4.129

10.  Treatment of weight regain after gastric bypass surgery when using a new endoscopic platform: initial experience and early outcomes (with video).

Authors:  Daniel K Mullady; David B Lautz; Christopher C Thompson
Journal:  Gastrointest Endosc       Date:  2009-06-24       Impact factor: 9.427

View more
  3 in total

1.  Modified-ESD Plus APC and Suturing for Treatment of Weight Regain After Gastric Bypass.

Authors:  Diogo Turiani Hourneaux de Moura; Pichamol Jirapinyo; Christopher C Thompson
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

2.  Five-year results of endoscopic gastrojejunostomy revision (transoral outlet reduction) for weight gain after gastric bypass.

Authors:  Zachary M Callahan; Bailey Su; Kristine Kuchta; John Linn; JoAnn Carbray; Michael Ujiki
Journal:  Surg Endosc       Date:  2019-07-25       Impact factor: 4.584

3.  Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study.

Authors:  Fritz F Horber; Rudolf Steffen
Journal:  Obes Surg       Date:  2020-07-21       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.